Catalyst Wire Dossier Catalyst Wire Dossier

Linagliptin/metformin (Jentadueto)

linagliptin/metformin · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Linagliptin/metformin (Jentadueto), covering 2012-04-25 to 2012-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Relative Bioavailability of Two Different Batches of a Linagliptin / Metformin Combination Tablet in Healthy Volunteers [Phase 1]

See pricing